Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Arkin Holdings

Founders Mori Arkin

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 27
Average round size
info
The average size of a deal this fund participated in
$38M
Portfolio companies 21
Rounds per year 1.93
Lead investments 4
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.19
Exits 1
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Therapeutics
  • Clinical Trials
Summary

Arkin Holdings is the famous Corporate Investor, which was founded in 2010. The main department of described Corporate Investor is located in the Herzliya. The company was established in Asia in Israel.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Arkin Holdings, startups are often financed by Accelmed, Office of the Chief Scientist of Israel - OCS. The meaningful sponsors for the fund in investment in the same round are Pontifax, Primera Capital, Pfizer. In the next rounds fund is usually obtained by Jerusalem Global Ventures.

Among the most popular portfolio startups of the fund, we may highlight Quiet Therapeutics, Metabomed, cCAM Biotherapeutics. The fund has no exact preference in some founders of portfolio startups. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most successful fund investment fields, there are Medical, Developer Platform. For fund there is a match between the location of its establishment and the land of its numerous investments - Israel.

The usual things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2015. The important activity for fund was in 2016. Opposing the other organizations, this Arkin Holdings works on 9 percentage points less the average amount of lead investments. Speaking about the real fund results, this Corporate Investor is 60 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Arkin Holdings:
Typical Co-investors
Arkin Holdings is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Arkin Holdings:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Israel
Funds with similar focus located in Israel:
Funds with the same geo focus
Funds with similar geography of portfolio companies:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
1898 Venture Capital Beijing, Beijing, China
3rd Creek Foundation Incline Village, Nevada, United States
Affiliated Managers Group Massachusetts, Prides Crossing, United States
Bukit Timah Capital Central, Central Region, Singapore
Cardiovascular Systems Minnesota, Saint Paul, United States
CMS Partners -
Edge Ventures China, Shanghai
Energiefonds Overijssel -
HNI Corporation Iowa, Muscatine, United States
Paramount Pictures California, United States, West Hollywood

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Nocion Therapeutics

Biotechnology
Health Care
Medical
$62M04 Mar 2024 Cambridge, Massachusetts, United States

NextPoint Therapeutics

Biotechnology
Health Care
Life Science
Therapeutics
$42M14 Feb 2024 Cambridge, Massachusetts, United States

Human Immunology Biosciences

Biotechnology
Life Science
Medical
Product Research
Therapeutics
$95M04 Jan 2024 San Francisco, California, United States

Percepto

Drones
Enterprise
Industrial Automation
Robotics
Software
$67M12 Jun 2023 Israel, Center District, Israel

Revamp Medical

Health Care
Medical Device
30 May 2023 Netanya, HaMerkaz, Israel

Pigmentum

Agriculture
AgTech
Biotechnology
$6M25 Jan 2023 Qiryat Shmona, HaZafon, Israel

Welcome Homes

Real Estate
Residential
$29M12 Jan 2023 New York, New York, United States

Phytolon

Biotechnology
Food and Beverage
Organic
$14M06 Jul 2022 Israel, North District, Israel

Eleos Health

Health Care
$20M05 Apr 2022 Cambridge, Massachusetts, United States
News
Eleos Health Raises $6M in Seed Funding

– Eleos Health is a Boston, MA- and Tel Aviv, Israel-based digital health startup.
– The company closed a $6M seed funding round.
– The round was led by aMoon Fund with participation from lool ventures, and Gandyr Group, alongside Arkin Holdings, Gaingels and former c-suite and executives from Google, MIT Media Lab, and Pegasystems.
– The company intends to use the funds for the expansion of sales, marketing, and solution delivery teams needed to meet the demand for enterprise software deployments across providers and payors.

Lendbuzz Raises $360M in Equity and Debt

– Lendbuzz is an AI-based auto finance platform that helps consumers with thin or no credit history obtain financing when purchasing a car.
– The company has raised $360m in funding.
– This includes: $60 million in Series C equity financing led by Wellington Management joined by Goldman Sachs & Co and MUFG Innovation Partners, as well as existing investors including 83North, Eyal Ofer’s O.G. Tech, Arkin Holdings, Mivtach Shamir and Highsage Ventures, and $300 million in debt financing led by Goldman Sachs Bank USA, joined by Viola Credit.
– The new investment will be aimed at continued business expansion within the U.S.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Arkin Holdings?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 27
Average round size 38M
Rounds per year 1.93
Peak activity year 2021
Lead investments 4
Follow on index 0.19
Exits 1
Group Appearance index 0.96

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Nocion Therapeutics

Biotechnology
Health Care
Medical
$62M04 Mar 2024 Cambridge, Massachusetts, United States

NextPoint Therapeutics

Biotechnology
Health Care
Life Science
Therapeutics
$42M14 Feb 2024 Cambridge, Massachusetts, United States

Human Immunology Biosciences

Biotechnology
Life Science
Medical
Product Research
Therapeutics
$95M04 Jan 2024 San Francisco, California, United States

Percepto

Drones
Enterprise
Industrial Automation
Robotics
Software
$67M12 Jun 2023 Israel, Center District, Israel

Revamp Medical

Health Care
Medical Device
30 May 2023 Netanya, HaMerkaz, Israel

Pigmentum

Agriculture
AgTech
Biotechnology
$6M25 Jan 2023 Qiryat Shmona, HaZafon, Israel

Welcome Homes

Real Estate
Residential
$29M12 Jan 2023 New York, New York, United States

Phytolon

Biotechnology
Food and Beverage
Organic
$14M06 Jul 2022 Israel, North District, Israel

Eleos Health

Health Care
$20M05 Apr 2022 Cambridge, Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: